These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22440859)

  • 1. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases.
    Čapkauskaitė E; Zubrienė A; Baranauskienė L; Tamulaitienė G; Manakova E; Kairys V; Gražulis S; Tumkevičius S; Matulis D
    Eur J Med Chem; 2012 May; 51():259-70. PubMed ID: 22440859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.
    Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D
    Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
    Čapkauskaitė E; Zubrienė A; Smirnov A; Torresan J; Kišonaitė M; Kazokaitė J; Gylytė J; Michailovienė V; Jogaitė V; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2013 Nov; 21(22):6937-47. PubMed ID: 24103428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases.
    Dudutienė V; Zubrienė A; Smirnov A; Timm DD; Smirnovienė J; Kazokaitė J; Michailovienė V; Zakšauskas A; Manakova E; Gražulis S; Matulis D
    ChemMedChem; 2015 Apr; 10(4):662-87. PubMed ID: 25758852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII.
    Čapkauskaitė E; Baranauskienė L; Golovenko D; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7357-64. PubMed ID: 20926301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII.
    Zubrienė A; Čapkauskaitė E; Gylytė J; Kišonaitė M; Tumkevičius S; Matulis D
    J Enzyme Inhib Med Chem; 2014 Feb; 29(1):124-31. PubMed ID: 23356363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
    Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazole-substituted benzenesulfonamides as inhibitors of 12 human carbonic anhydrases.
    Čapkauskaitė E; Zubrienė A; Paketurytė V; Timm DD; Tumkevičius S; Matulis D
    Bioorg Chem; 2018 Apr; 77():534-541. PubMed ID: 29459130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases.
    Vaškevičienė I; Paketurytė V; Pajanok N; Žukauskas Š; Sapijanskaitė B; Kantminienė K; Mickevičius V; Zubrienė A; Matulis D
    Bioorg Med Chem; 2019 Jan; 27(2):322-337. PubMed ID: 30553625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase.
    Ceruso M; Del Prete S; AlOthman Z; Osman SM; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem Lett; 2014 Aug; 24(16):4006-10. PubMed ID: 25011913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.
    Poulsen SA; Wilkinson BL; Innocenti A; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4624-7. PubMed ID: 18644716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV.
    Gavernet L; Gonzalez Funes JL; Palestro PH; Bruno Blanch LE; Estiu GL; Maresca A; Barrios I; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1410-8. PubMed ID: 23266178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogenated and di-substituted benzenesulfonamides as selective inhibitors of carbonic anhydrase isoforms.
    Zakšauskas A; Čapkauskaitė E; Jezepčikas L; Linkuvienė V; Paketurytė V; Smirnov A; Leitans J; Kazaks A; Dvinskis E; Manakova E; Gražulis S; Tars K; Matulis D
    Eur J Med Chem; 2020 Jan; 185():111825. PubMed ID: 31740053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship.
    Gao R; Liao S; Zhang C; Zhu W; Wang L; Huang J; Zhao Z; Li H; Qian X; Xu Y
    Eur J Med Chem; 2013 Apr; 62():597-604. PubMed ID: 23429054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases.
    Zakšauskas A; Čapkauskaitė E; Jezepčikas L; Linkuvienė V; Kišonaitė M; Smirnov A; Manakova E; Gražulis S; Matulis D
    Eur J Med Chem; 2018 Aug; 156():61-78. PubMed ID: 30006175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
    Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.